UNSPSC 51202202: Laquinimod

This classification denotes an immunosuppressant, a biological preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 908SY76S4G, chemically known as 5-chloro-n-ethyl-4-hydroxy-1-methyl-2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide but more generally known as laquinimod, which bears US NIH Compound Identifier 54677946. European Medicines Agency schedules umirolimus in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25236.

Most nations, for tariff and trade purposes, schedule LAQUINIMOD under HS 29337900 amd SITC 51561. SMILES: CCN(C1=CC=CC=C1)C(=O)C2=C(C3=C(C=CC=C3Cl)N(C2=O)C)O.

UNSPSC 51202202 Laquinimod is a Commodity code nominally identifying a single pharmaceutical product, but the recent state and local opportunities tagged under this code show little connection to laquinimod specifically. Instead, the three most recent solicitations span athletic training services, medical aid supplies, and pharmacy benefit management — none of which align with the procurement of a disease-modifying antirheumatic drug. The City of Tucson issued an RFP for comprehensive athletic training services for fire and police departments, requiring NATA BOC-certified trainers with three years' experience and physician oversight, with contract options extending to five years. The City of Tampa's Fire Rescue Department posted an ITB for routine first-aid and medical supplies including bandages, antiseptic, aspirin, and emergency blankets with a $100,000 departmental budget and set-asides for City-certified Small Local Business Enterprises and underutilized minority-owned firms. The Texas Health and Human Services Commission issued a Request for Information seeking vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, exploring direct contracting models outside traditional pharmacy benefit managers and group purchasing organizations.

Activity under this code spans three states — Arizona (Tucson), Florida (Tampa), and Texas (HHS) — with issuing bodies including city governments and a state health agency. The Tucson athletic training RFP closed June 9, 2026, the Tampa Fire Rescue medical supplies ITB was due April 9, 2025 (now past), and the Texas HHS Commission's RFI closed April 3, 2026. The code shows no coherent recent procurement pattern aligned with laquinimod or any single pharmaceutical commodity. The mismatch between the code's nominal scope and actual recent opportunities suggests either systematic miscoding in state procurement systems or that this UNSPSC designation is not actively used for its intended product category in current state and local buying activity.